Abstract

Recurrent events often serve as the outcome in epidemiologic studies. In some observational studies, the goal is to estimate the effect of a new or "experimental" (i.e., less established) treatment of interest on the recurrent event rate. The incentive for accepting the new treatment may be that it is more available than the standard treatment. Given that the patient can choose between the experimental treatment and conventional therapy, it is of clinical importance to compare the treatment of interest versus the setting where the experimental treatment did not exist, in which case patients could only receive no treatment or the standard treatment. Many methods exist for the analysis of recurrent events and for the evaluation of treatment effects. However, methodology for the intersection of these two areas is sparse. Moreover, care must be taken in setting up the comparison groups in our setting; use of existing methods featuring time-dependent treatment indicators will generally lead to a biased treatment effect since the comparison group construction will not properly account for the timing of treatment initiation. We propose a sequential stratification method featuring time-dependent prognostic score matching to estimate the effect of a time-dependent treatment on the recurrent event rate. The performance of the method in moderate-sized samples is assessed through simulation. The proposed methods are applied to a prospective clinical study in order to evaluate the effect of living donor liver transplantation on hospitalization rates; in this setting, conventional therapy involves remaining on the wait list or receiving a deceased donor transplant.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.